SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-172392
Filing Date
2014-04-30
Accepted
2014-04-30 16:36:43
Documents
10
Period of Report
2014-06-27
Effectiveness Date
2014-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d716525ddef14a.htm DEF 14A 438941
2 GRAPHIC g716525g49c36.jpg GRAPHIC 11839
3 GRAPHIC g716525g52k26.jpg GRAPHIC 7343
4 GRAPHIC g716525g68m57.jpg GRAPHIC 7333
5 GRAPHIC g716525pc_pg01a.jpg GRAPHIC 35781
6 GRAPHIC g716525pc_pg01b.jpg GRAPHIC 40476
7 GRAPHIC g716525pc_pg01c.jpg GRAPHIC 1101
8 GRAPHIC g716525pc_pg01d.jpg GRAPHIC 1375
9 GRAPHIC g716525pc_pg01e.jpg GRAPHIC 16204
10 GRAPHIC g716525pc_pg02.jpg GRAPHIC 31392
  Complete submission text file 0001193125-14-172392.txt   652256
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 14799439
SIC: 2834 Pharmaceutical Preparations